EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, SMHGF: Simcere Pharmaceutical Group Ltd

10 Dec 2025
LAST:

1.960

CHANGE:
 0.07		OPEN:
1.960		HIGH:
1.960		ASK:
0.000		VOLUME:
100
CHG(%):
8.74		PREV:
0.759		LOW:
1.960		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Simcere Pharmaceutical Group Ltd
About:Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.
Sector:Healthcare
Address:No. 699-18, Xuanwu Road, Nanjing, China, 210042
Website:https://www.simcere.com
FIGI:BBG00Y0BY0S2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:17.31 
Price to Sales:0.62 
Price to Book:1.78 
DivYield:0.23 
Div/Share:0.16 
Revenue:7.107B 
EBITDA:1.485B 
Shares:2.596B 
Market Cap:5.088B